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Abstract
Q fever, caused by Coxiella burnetii, is a serious zoonotic disease in humans with a world-
wide distribution. Many species of animals are capable of transmitting C. burnetii, and con-
sequently all veterinary workers are at risk for this disease. An effective Q fever vaccine has
been readily available and used in Australia for many years in at-risk groups, and the Euro-
pean Centre for Disease Prevention and Control has recently also called for the use of this
vaccine among at-risk groups in Europe. Little is known about attitudes towards this vaccine
and vaccine uptake in veterinary workers. This study aimed to determine the Q fever vacci-
nation status of veterinarians and veterinary nurses in Australia and to assess and compare
the knowledge and attitudes towards Q fever disease and vaccination of each cohort. An
online cross-sectional survey performed in 2014 targeted all veterinarians and veterinary
nurses in Australia. Responses from 890 veterinarians and 852 veterinary nurses were
obtained. Binary, ordinal and multinomial logistic regression were used to make compari-
sons between the two cohorts. The results showed that 74% of veterinarians had sought
vaccination compared to only 29% of veterinary nurses. Barriers to vaccination among
those not vaccinated did not differ between cohorts, and included a lack of perceived risk,
financial expense, time constraints, and difficulty in finding a vaccine provider. Poor knowl-
edge and awareness of Q fever disease and vaccination were additional and notable barri-
ers for the veterinary nursing cohort, suggesting veterinary clinics and veterinarians may
not be meeting their legal responsibility to educate staff about risks and risk prevention. Fur-
ther evaluation is needed to identify the drivers behind seeking and recommending vaccina-
tion so that recommendations can be made to improve vaccine uptake.
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Introduction
Q fever is a serious zoonotic disease capable of causing chronic debilitating and life threatening,
illness in humans [1]. Following infection by the causative bacterium Coxiella burnetii, about
40% of patients become symptomatic in the acute phase, with symptoms most often limited to
a flu-like illness. However, 2–5% of acute Q fever patients develop severe complications such as
hepatitis, atypical pneumonia, myocarditis or meningitis [1–5]. Acute infection during preg-
nancy has been associated with miscarriage, foetal death, premature delivery and low birth
weights, with women in their first trimester at greatest risk [6–8].
Chronic Q fever may develop months or years after acute infection, with immunocompro-
mised or pregnant patients predisposed, as are those with pre-existing heart valve lesions, vas-
cular disease or prosthetic joints [8,9]. Endocarditis is the most common presentation of
chronic Q fever reported [9,10]. Chronic Q fever fatigue syndrome (QFS) is another well recog-
nised sequelae to acute Q fever, occurring in up to 10% of patients, and is related to the persis-
tence of C. burnetii antigens within the host in the absence of viable bacteria [11–13]. Women
with chronic Q fever may experience recurrent miscarriage or pre-term deliveries [7]. Due to
the non-specific and variable presentations of both acute and chronic Q fever, diagnosis may
be delayed in the absence of a high index of suspicion, prolonging illness and endangering the
lives of those affected [14,15].
C. burnetii is shed in greatest numbers in the products of conception, and to a lesser extent
the urine, faeces, milk and saliva of infected animals [1,16]. The bacterium exhibits a spore-like
stage of its lifecycle, which is extremely resistant to environmental and chemical insults allow-
ing for survival outside the host for longer than 12 months [1,17,18]. Inhalation is the most
common route of infection, with C. burnetii easily dispersed by wind over large areas [19].
A wide variety of domestic and wild animal species act as a reservoir for C. burnetii. To date
most human infections have been attributed to cattle, sheep and goats [1] which has led to a gen-
eral belief that Q fever is a disease of production animal workers and those living in rural com-
munities. However, studies in Australia and Japan have demonstrated seroprevalence for C.
burnetii to be similar among people in rural and metropolitan areas of some regions [20,21] sug-
gesting that alternative sources such as companion and wild animals may be an under-recognised
contributor to Q fever infection [22]. Indeed there are an increasing number of reported cases of
Q fever in humans that have been attributed to companion animals [23–26]. Parturient cats have
been implicated across the globe since the 1980’s [23] with cats now considered a significant
source of Q fever disease in Japan and Maritime Canada [3,23] and a potential source of disease
in Korea, the United States of America (USA), the United Kingdom and Australia [26–31]. Dogs
and horses have also been identified as a source of Q fever disease around the world [24,25,32–
34]. With a broad range of species capable of transmitting C. burnetii, the occupational risk to
veterinary workers is undeniable, regardless of their practice type. Outbreaks among veterinary
workers have been associated with direct or indirect contact with birth products following cat
and dog caesareans in small animal veterinary clinics [25,26,35]. Studies in Japan, Denmark, the
Netherlands and the USA have confirmed a significantly higher seropositivity to C. burnetii
among veterinarians compared to the general population [21,36–38], while Q fever was the sec-
ond most common zoonosis reported among Australian veterinarians in a recent survey [39].
A whole cell formalin-inactivated Q fever vaccine (Q-Vax1; CSL Biotherapies, Parkville,
Vic.) has been available in Australia since 1989 and has a reported efficacy of over 98% [40]. To
date, routine use and licensing has been restricted to Australia, in part due to a perception that
the vaccine is “old-fashioned” and concerns regarding adverse events following immunisation
[41,42]. Any persons who have previously had Q fever or exposure to C. burnetii should not
receive the vaccination due to an increased risk of adverse events following immunisation [43].
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Strict pre-vaccination protocols have been successfully implemented in Australia to minimise
the risk of adverse events; serology and intradermal skin testing with diluted vaccine to check
for evidence of prior exposure. This process requires experienced medical practitioners and
may be seen as costly and time consuming [44].
Currently, the Australian Veterinary Association (AVA) Biosecurity Guidelines and the
Australian Immunisation Handbook recommend vaccination of all veterinarians, veterinary
students and veterinary nurses [45,46]. The vaccination process is now a course requirement
for students enrolled in veterinary and animal science degrees at Australian universities. Out-
side of this tertiary environment, Q fever vaccination may be recommended or a compulsory
requirement to commence employment for some veterinary and other animal workers.
The European Centre for Disease Prevention and Control has released recommendations
for the use of this vaccine in targeted groups, including veterinary workers, in European coun-
tries while a new-generation vaccine is being developed [41]. The implementation of routine Q
fever vaccination internationally would come at some expense, and lessons from the Australian
experience could help to mitigate cost and time.
The aim of this study was to determine the Q fever vaccination status and compare the
knowledge, attitudes and practices of veterinarians and veterinary nurses in Australia to Q
fever with the further aim of informing vaccine policy both in Australia and internationally
and making recommendations to maximise workplace health and safety (WH&S) for all veteri-
nary personnel.
Methods
Study Design
This cross-sectional study was targeted at all veterinarians and veterinary nurses in Australia
over 18 years of age and currently or recently employed in a veterinary workplace. The study
was implemented via the Survey Monkey1 (Palo Alto, California, USA) platform as an online
questionnaire containing 53 questions (13 open, 25 closed and 15 semi-closed) divided across
six sections; (1) demographics and veterinary work environment, (2) attitudes towards Q fever
illness and vaccination, (3) experience with Q fever disease, (4) experience with Q fever vacci-
nation, (5) knowledge of disease risk, and (6) biosecurity practices. Skip logic was used and it
was not compulsory to answer all questions. Ethics approval was granted by Charles Sturt Uni-
versity School of Animal and Veterinary Sciences Human Ethics Committee (protocol #416/
2013/19). A participant information statement was provided to participants and informed con-
sent was sought prior to commencement of the survey.
Recruitment of veterinary nurses
Veterinary nurses were recruited during March and April of 2014. Due to limitations in access-
ing this unique workforce, which requires no formal registration outside of the state of Western
Australia, participants were recruited in a number of ways. A personal email invitation con-
taining a link to the survey was sent on our behalf by the Veterinary Surgeon’s Board of West-
ern Australia to all veterinary nurses in this state using the email address listed with the board.
In other states and territories, attempts were made to phone all veterinary clinics to invite
veterinary nurses to participate in the survey. The clinic phone lists for New South Wales and
Tasmania were compiled from practice lists provided by the state’s respective veterinary practi-
tioner’s boards whilst the remaining state lists were compiled from all clinics listed with the
Yellow Pages1 phone book. Reminder emails/letters/faxes were sent out two weeks after the
first email, letter or fax. The Veterinary Nursing Council of Australia (VNCA) also sent per-
sonal emails to members for whom they had an email address recorded.
Q Fever Vaccination and Australia’s VeterinaryWorkforce in 2014
PLOS ONE | DOI:10.1371/journal.pone.0146819 January 12, 2016 3 / 18
Recruitment of veterinarians
Initial contact with veterinarians was made through an invitation advertised in the AVA’s
email newsletter sent to all members on the 11th of April 2014. In May and June of 2014 veteri-
narians were recruited in a similar fashion to veterinary nurses. Personal email invitations were
sent on our behalf by state veterinary surgeons boards where possible. In other states, the con-
tact lists compiled for distributing the survey to clinics for participation of veterinary nurses
were revised for the recruitment of veterinarians. Clinics that had previously declined partici-
pation of their veterinary nurses were contacted to invite participation from veterinarians and
phone calls were also made to check method of contact preference where post or fax had been
previously specified. Reminder emails/letters/faxes were sent out 2 weeks after the first. During
May 2014, the Veterinary Practitioners Board of NSW also provided details and a link to the
survey on their website, which had increased traffic during this month as it coincided with vet-
erinarians’ registration renewals.
Data management and analysis
Binary, ordinal and multinomial logistic regression analyses were undertaken to compare the
knowledge, attitudes and practices between veterinarian and veterinary nurse cohorts (the
exposure) and all models were adjusted for age, sex and state to account for demographic dif-
ferences of the cohorts. P-values of<0.05 were considered statistically significant and 95% con-
fidence intervals (CI) were calculated. For ordinal outcomes, the assumption of proportionality
was evaluated using the Score Test. Where the Score Test was found to be significant (p<0.05),
indicating that the assumption was invalid, categories were combined to create binary variables
or if appropriate multinomial logistic regression was undertaken.
Agreement with attitudinal statements regarding the importance of, potential harm from,
and difficulty in accessing the Q fever vaccination were compared between the two cohorts using
binary logistic regression with the positive outcome ‘agree’. Q fever knowledge was assessed as
self-reported knowledge, with participants asked to rate their level of Q fever knowledge on a
scale of one (lowest) to ten (highest), and a Kruskal-Wallis Test undertaken to assess for a statisti-
cal difference between the mean rank of each cohort. Perception of vaccine safety, efficacy and
expense was compared with ordinal logistic regression. The positive outcome “agree/strongly
agree” was modelled over lower levels of agreement in veterinarians compared to veterinary
nurses. Self-perceived level of risk (nil, low, moderate, high) of personal exposure to C. burnetii
was compared between the two cohorts using multinomial logistic regression. Odds ratios were
calculated for veterinarians versus veterinary nurses, with logits modelled using ‘nil’ exposure as
the reference category. Respondents were considered to have attempted vaccination if they
reported that they had been vaccinated or were positive at pre-vaccination screening. Odds of
attempting vaccination and odds of receiving vaccination were compared using separate binary
logistic regression models with the positive outcomes ‘attempted vaccination’ and ‘vaccinated’,
respectively. Multinomial logistic regression was used to determine the odds of vaccination of
each cohort across the three most likely vaccination scenarios; (1) actively sought vaccination
despite no workplace or study requirement to do so, (2) vaccinated as a requirement of work (3)
vaccinated due to a university/ other course requirement.
Practice structures were defined as ‘solo’ (one veterinarian within the clinic), ‘group’ (multi-
ple veterinarians within the clinic), ‘corporate’ (multiple veterinarians with a clinic owned and
managed by a corporate entity), ‘university’ (clinical, research and/or academia within a uni-
versity) or ‘other’. Practice type by species was determined by the combination of species with
which respondents spent>90% of their working hours with. Responses stating “don’t know”
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or “unsure” were excluded from all comparisons. All analyses were performed in SAS1 statis-
tical program (2002–2012 SAS Institute Inc; Cary, NC, USA).
Results
Sampling
A total sample size of 1,742 participants was achieved, comprised of 852 veterinary nurses and
890 veterinarians.
Of the 995 veterinary nurses registered with the Western Australia state veterinary board,
113 were not contactable for this survey due to the absence of a registered email address. The
remaining 882 were individually emailed an invitation to participate, although 74 of these
emails were subsequently undeliverable. In other states of Australia, phone calls were made to
1,677 clinics inviting participation of veterinary nurses. Of the 1,446 clinics who agreed to
receive participation details, 1,286 preferred to receive an email link to the survey (54 of these
emails were subsequently undeliverable), while 91 were sent survey details via post and 69 via
fax. Personal emails were sent to 917 VNCAmembers.
Sampling of veterinarians conducted via email invitations sent on our behalf by state veteri-
nary practitioners boards resulted in individual emails sent to 1200 veterinarians in Western
Australia and 245 veterinarians in Tasmania. The number of veterinarians registered with
these state boards and the number of undeliverable email invitations were not able to be
obtained. In the remaining states contacted initially via phone, 1582 clinics agreed to partici-
pate with 1458 sent an email link to the survey (23 of these emails were undeliverable), while
survey details were sent to 82 clinics via post and 42 clinics via fax. It is not known how many
veterinarians accessed the survey via the AVA’s email newsletter (which was viewed by 2537
members), or the NSW veterinary surgeon’s board website.
Demographics and veterinary work
Although an accurate response rate was unable to be determined from this survey due to the
absence of a single registry by which all veterinarians and veterinary nurses could be contacted,
it was estimated that participation by 890 veterinarians and 852 veterinary nurses represented
approximately 12% of the estimated 7,400 employed veterinarians and 10% of the estimated
8,600 employed veterinary nurses at the time according to Australian government employment
statistics [47,48]. All states and territories were represented The majority of veterinary nurses
were female (98%), compared to 63% of veterinarians, and the nursing cohort was, both in
range of years and on average, younger and reported fewer years in the veterinary workforce
(Table 1). Both cohorts mostly worked in small animal practice with a group practice structure
predominating (Table 1). The reported number of staff in clinics ranged from one to 299 with
a median number of ten and interquartile range of ten, indicating that most clinics would be
categorised as small businesses. In terms of education, most (65%) veterinary nurses had com-
pleted Certificate IV level training at a technical tertiary institution although 13% reported no
formal education. The veterinarians responding to the survey were mostly graduates of Austra-
lian universities (89%), with all seven Australian veterinary schools represented, and 35% of
respondents held additional postgraduate qualifications (S1 Table).
Attitudes towards vaccination
The majority of both cohorts (97%) agreed that vaccines in general are important in the pre-
vention of disease. In comparison with veterinary nurses, veterinarians had higher odds (2.18;
95% CI 1.44–3.38; p<0.001) of being convinced of the importance of the Q fever vaccine and
Q Fever Vaccination and Australia’s VeterinaryWorkforce in 2014
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lower odds (0.53; 95% CI 0.38–0.74; p<0.001) of being concerned that the vaccine may be
harmful (Table 2). Greater than 40% of each cohort agreed that the vaccine was difficult to
access, with veterinarians reporting lower odds (0.77; 95% CI 0.60–0.97; p = 0.03) of agreement
with this statement (Table 2).
Table 1. Demographics and veterinary work of participants in study of Q fever knowledge attitudes and practices in 2014 in Australia.
Veterinarians (n = 890) Veterinary Nurses (n = 852)
Characteristic No.(%)a No.(%)a
Sex
Female 560 (63%) 836 (98%)
Male 321 (36%) 14 (2%)
Not speciﬁed 9 (1%) 2 (<1%)
Age
Range 21–80 years 18–69 years
Mean 40 years 33 years
Median 38 years 31 years
Standard deviation 12 years 10 years
Interquartile Range 19 years 16 years
18–30 years 251 (28%) 403 (48%)
31–40 years 238 (27%) 229 (27%)
41–50 years 202 (23%) 144 (17%)
51+ years 194 (22%) 68 (8%)
Years working
Range 0.2–60 years 0.3–47 years
Mean 16.2 years 10 years
Median 14 years 8 years
Standard deviation 12 years 8 years
Interquartile Range 19 years 10 years
0.2–5 years 192 (22%) 305 (37%)
6–10 years 172 (20%) 222 (27%)
11–20 years 225 (26%) 219 (26%)
21–30 years 157 (18%) 64 (8%)
31+ years 128 (15%) 21 (3%)
Practice Type
Small animals 512 (58%) 640 (75%)
Farm/mixed animals 297 (33%) 132 (15%)
Equine/other 37 (4%) 17 (2%)
Not speciﬁed 44 (5%) 63 (7%)
Practice Structure
Corporateb 32 (4%) 48 (6%)
Groupc 575 (65%) 441 (52%)
Solod 169 (19%) 256 (30%)
University 31 (3%) 36 (4%)
Other 45 (5%) 19 (2%)
Not speciﬁed 38 (4%) 52 (6%)
aUnless speciﬁed otherwise. Percentages are of total respondents for each parameter. Not all participants responded to all questions.
bOne veterinarian within the clinic
cMultiple veterinarians within the clinic
dMultiple veterinarians within a clinic owned and managed by a corporate entity.
doi:10.1371/journal.pone.0146819.t001
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Knowledge and perceptions of Q fever vaccination and disease
The majority of both cohorts (98%) agreed (slightly agreed/agreed/strongly agreed) that Q
fever is a serious disease with significant health consequences. Self-reported Q fever knowledge
on a scale of one (lowest) to ten (highest) was normally distributed among veterinarians
(mean = 5; median = 5), while that of veterinary nurses was positively skewed (mean = 3.5;
median = 3) (Fig 1). The Kruskal-Wallis Test identified a significant difference (p<0.001) in
knowledge between the cohorts. Veterinarians had 1.5 times (95% CI 1.1–2.1; p = 0.03) odds of
agreeing that the vaccine is safe, 3.3 times (95% CI 2.2–5.1; p<0.001) odds of agreeing that the
vaccine is effective and 0.35 times (95% CI 0.26–0.47; p<0.001) odds of agreeing that the vac-
cine is expensive compared to veterinary nurses (Table 3). The cost, safety and efficacy of the Q
fever vaccine was not known among 43% (342/802), 13% (102/807) and 21% (168/805) of vet-
erinarians and 50% (358/716), 26% (187/722) and 31% (221/722) of veterinary nurses
respectively.
Exposure to C. burnetii
Both cohorts considered the risk of exposure to C. burnetii to be similar for both veterinarians
and veterinary nurses within each practice type (Fig 2). Ordinal regression analysis of perceived
level of exposure to C. burnetii did not meet the assumption of proportionality and binary cate-
gories were not appropriate. Subsequently multinomial regression was undertaken which,
when adjusted for practice type, revealed veterinarians had 12.5 times (95% CI 6.4–25.1;
p<0.001) the odds of stating their personal risk as high rather than nil compared to veterinary
nurses (Table 4). Alarmingly, 11% (93/850) of veterinarians and 25% (201/793) of veterinary
nurses stated they “did not know” their level of exposure and a further 11% (150/793) of veteri-
nary nurses stated ‘nil exposure’. Of those veterinary nurses stating ‘nil exposure’, 91% worked
within small animal practices, 7% in large and mixed animal practices, and the remainder in
equine or other practices.
Table 2. Binary logistic regression analysis of attitudes towards the Q fever vaccine among veterinarians and veterinary nurses surveyed in Aus-
tralia in 2014.
Agree Disagree Total Adjusted Odds Ratioab 95% CIc P-valued
"If a vaccine exists for a certain disease, then vaccination is usually a good way to protect someone against this disease"
Nurses 727 (97%) 20 (3%) 747 1
Vets 805 (97%) 22 (3%) 827 1.13 0.55–2.35 0.75
"I am convinced of the importance of the Q fever vaccine"
Nurses 645 (88%) 86 (12%) 731 1
Vets 765 (93%) 54 (7%) 819 2.18 1.44–3.38 <0.001
"I worry that the Q fever vaccine will do more harm than good"
Nurses 131 (18%) 600 (82%) 731 1
Vets 96 (12%) 723 (88%) 819 0.53 0.38–0.74 <0.001
"It is difﬁcult to get vaccinated for Q fever"
Nurses 312 (44%) 404 (56%) 716 1
Vets 327 (41%) 479 (59%) 806 0.77 0.60–0.97 0.03
aOdds of stating “agree”
bRatio adjusted for age, sex and state
cConﬁdence interval
dLikelihood ratio Chi-square p-value.
doi:10.1371/journal.pone.0146819.t002
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Vaccination status and barriers to vaccination
The majority of veterinarians (587/796; 74%) were either vaccinated (488/587; 61%) or had
sought vaccination for Q fever but were unable to be vaccinated due to a positive pre-vaccina-
tion screening result (99/587; 12%). This proportion increased to 78% (562/721) among gradu-
ates of Australian veterinary schools and decreased to only a third (25/75; 33%) among
international graduates (Table 5). Only 29% (199/688) of veterinary nurses had been vacci-
nated (162/199; 24%) or had sought vaccination but were unable to be vaccinated due to a
positive pre-vaccination screening result (37/162; 5%) (Table 5). Overall, veterinarians had
Table 3. Ordinal logistic regression analysis of the perceptions of the Q fever vaccination among veterinarians and veterinary nurses surveyed in
Australia in 2014.
Strongly disagree/ disagree Slightly disagree Slightly agree Agree/ strongly agree Total Adjusted ORab 95% CI P-valuec
"The Q fever vaccine is safe if appropriately administered"
Nurses 4 (<1%) 12 (2%) 78 (15%) 441 (82%) 535 1
Vets 3 (<1%) 19 (3%) 71 (10%) 612 (87%) 705 1.49 1.05–2.13 0.027
"The Q fever vaccine is effective in preventing Q fever"
Nurses 5 (1%) 15 (3%) 84 (17%) 397 (79%) 501 1
Vets 1 (<1%) 6 (1%) 43 (7%) 587 (92%) 637 3.3 2.19–5.08 <0.001
"The Q fever vaccine is too expensive"
Nurses 90 (25%) 50 (14%) 100 (28%) 118 (33%) 358 1
Vets 236 (51%) 71 (15%) 76 (16%) 78 (17%) 461 0.35 0.26–0.47 <0.001
aOdds Ratio: odds of stating “agree/strongly agree” modelled over the lower levels of agreement. Assumption of proportionality met.
bAdjusted for age, sex and state.
cWald Chi-square P-value.
doi:10.1371/journal.pone.0146819.t003
Fig 1. Boxplot of self-rated Q fever knowledge among veterinarians and veterinary nurses.
doi:10.1371/journal.pone.0146819.g001
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13 times (95% CI 9.9–18.1; p<0.001) odds of having attempted vaccination and 10 times (95%
CI 7.6–12.6; p<0.001) odds of having received the vaccination.
Among those who had attempted vaccination, a positive pre-vaccination screening result
was reported by 17% (99/587) of veterinarians and 19% (37/199) of veterinary nurses. Among
veterinarians graduating from Australian veterinary schools this percentage fell slightly to 15%
(84/562) while 60% (15/25) of international graduates who had attempted vaccination were
found to be positive at pre-vaccination screening.
Veterinarians mostly (81%) received their vaccination as a requirement of a university
course while veterinary nurses were commonly vaccinated as a job requirement (43%). Multi-
nomial regression revealed veterinary nurses had twice the odds (95% CI 1.2–5.0; p = 0.02) of
having been vaccinated as a job requirement than having actively sought vaccination outside of
a job requirement than veterinarians, while veterinarians had 19 times (95% CI 9.1–40.7;
Fig 2. Perceived exposure risk of veterinarians and veterinary nurses to C. burnetii across different practice types.
doi:10.1371/journal.pone.0146819.g002
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p<0.001) odds of having been vaccinated as a university/course requirement than having
actively sought vaccination outside of a job requirement than veterinary nurses.
Among respondents who had not attempted Q fever vaccination, 27% (57/209) of veterinar-
ians and 42% (205/489) of veterinary nurses were not aware the vaccine existed (Table 5). Rea-
sons for non-vaccination among those aware of its existence did not differ significantly
between the two cohorts, with the perception that “I will not be seriously affected by Q fever”
identified as the most influential reason for not seeking vaccination (Table 6).
Seven participants who were not vaccinated commented that their medical practitioner had
little knowledge of, or had advised against, Q fever vaccination. Such comments included;
“I have seen two GP's. . .regarding Q fever vaccination. . . neither one had any real idea of what
was involved. . . one looked it up and made me feel the risks of vaccination were too high.”
“My doctor when questioned about the existence of this vaccine did not believe that it existed.”
“My doctor was under the impression you only need this vaccine if you are travelling overseas.”
Sources of biosecurity information
Clinic protocols and veterinarians within the workplace were identified by participants as the
most influential sources of biosecurity information for both veterinarian and veterinary nurse
cohorts (Fig 3).
Table 4. Multinomial logistic regression analysis of level of perceived personal exposure toC. burnetii among veterinarians versus veterinary
nurses surveyed in Australia in 2014.
Nil Low Exposure Moderate Exposure High Exposure
n (%) n (%) Adjusted
ORa
95%
CI
p-
valueb
n (%) Adjusted
ORa
95%
CI
p-
valueb
n (%) Adjusted
ORa
95%
CI
p-
valueb
Nurses
(n = 793)
151
(19%)
329
(41%)
1 88
(11%)
1 24
(3%)
1
Vets
(n = 850)
33
(4%)
414
(49%)
5.4 3.5–
8.7
<0.001 216
(25%)
8.2 4.8–
13.9
<0.001 94
(11%)
12.5 6.4–
25.1
<0.001
aOdds Ratio; logits modelled using "nil exposure" as the reference category and adjusted for age, sex, state and practice type.
bWald Chi-square p-value.
doi:10.1371/journal.pone.0146819.t004
Table 5. Q fever vaccination status of veterinarians and veterinary nurses surveyed in Australia in 2014.
All vets (n = 796) Vets graduated in Australia (n = 721) Vets graduated internationally (n = 75) Nurses (n = 688)
n (%) n (%) n (%) n (%)
Attempted vaccination
Vaccinated 488 (61%) 478 (66%) 10 (13%) 162 (24%)
Pre-screen positive 99 (12%) 84 (12%) 15 (20%) 37 (5%)
Total attempted 587 (74%) 562 (78%) 25 (33%) 199 (29%)
Not attempted vaccination
Not aware of the vaccine 57 (7%) 38 (5%) 19 (25%) 205 (30%)
Aware of the vaccine 152 (19%) 121 (17%) 31 (41%) 284 (41%)
Total not attempted 209 (26%) 159 (22%) 50 (67%) 489 (71%)
doi:10.1371/journal.pone.0146819.t005
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Discussion
This study investigated the knowledge, attitudes and practices of Australia’s veterinary work-
force regarding Q fever disease and vaccination and made comparisons between veterinarians
and veterinary nurses. The key finding of this study was a shortfall in Q fever vaccine uptake
among the veterinary nursing cohort, with less than a third of participants reporting they had
sought vaccination. This was particularly disconcerting as the majority of veterinary nurses
participating in the survey were women of child bearing age, who could potentially face an
increased risk of chronic disease outcomes if they were to contract Q fever while pregnant [8].
In contrast, the majority of veterinarians had sought vaccination with uptake similar to that
observed in abattoir workers during Australia’s National Q Fever Vaccination Program [49]
and for other occupational diseases among medical professions [50]. The discrepancy between
veterinarians and veterinary nurses seeking vaccination was observed despite the overwhelm-
ing majority of both cohorts agreeing that Q fever is a serious disease and that vaccinations are
important for prevention of serious diseases. It is important to understand why this gap in vac-
cine uptake exists to improve Q fever vaccine uptake by veterinary nurses within Australia and
to inform the potential introduction of the Q fever vaccine to at-risk cohorts internationally.
Some answers to the question of why veterinary nurses have a lower Q fever vaccination
rate were evident from the study and can be supported by theories of health behaviour models
[51]. The first step towards vaccination primarily requires some knowledge and awareness of
both the health risk Q fever poses and the availability of a vaccine [51,52]. Veterinary nurses
however reported a notable lack of awareness of the Q fever vaccine and a particularly low level
of self-reported Q fever knowledge. Since veterinary nurses identified workplace protocols and
Table 6. Proportional odds of the influence of known barriers to vaccination among veterinary nurses versus veterinarians surveyed in Australia
in 2014.
Inﬂuence Total Adjusted ORab 95% CI p-valueb
Nil n(%) Minor/ Moderate n(%) Major/ sole n(%)
Unable to access a Q fever vaccine provider
Nurses 194 (71%) 39 (14%) 41 (15%) 274 1
Vets 98 (66%) 28 (19%) 22 (15%) 148 0.66 0.34–1.28 0.21
Q fever vaccine may not be effective
Nurses 234 (86%) 35 (13%) 4 (1%) 273 1
Vets 128 (87%) 17 (12%) 2 (1%) 147 1.65 0.65–4.62 0.305
Unable to afford the ﬁnancial cost of vaccination
Nurses 173 (63%) 65 (24%) 36 (13%) 274 1
Vets 116 (78%) 22 (15%) 10 (7%) 148 1.19 0.60–2.43 0.628
Q fever vaccination may be harmful
Nurses 211 (77%) 55 (20%) 8 (3%) 274 1
Vets 109 (74%) 34 (23%) 4 (3%) 147 0.91 0.45–1.91 0.648
Pre-screening and vaccination process is too time consuming
Nurses 198 (72%) 61 (22%) 15 (5%) 274 1
Vets 100 (68%) 31 (21%) 15 (10%) 146 0.53 0.26–1.06 0.063
Perception that "I won't be seriously affected by Q fever"
Nurses 134 (49%) 82 (30%) 60 (22%) 276 1
Vets 72 (49%) 35 (24%) 41 (28%) 148 1.04 0.58–1.88 0.893
aOdds Ratio: odds of stating “major/sole inﬂuence” modelled over the lower levels of inﬂuence. Proportionality assumption was met.
bWald Chi-square p-value.
doi:10.1371/journal.pone.0146819.t006
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veterinarians within their workplace as the two main sources from which they obtained biose-
curity information, the shortfall in the two fundamental areas of awareness and knowledge
may point to a failure of workplace health and safety (WH&S) protocols in the practices in
which these veterinary nurses were employed as well as a failure of their veterinary colleagues
to provide adequate information and WH&S training regarding Q fever. This is consistent with
other studies calling for improved WH&S training within veterinary clinics both in Australia
and internationally [39,53–57]. Once aware of the risks associated with Q fever and the avail-
ability of a Q fever vaccination, the formation of an intention to seek vaccination relies on an
individual’s attitudes, both positive and negative, associated with seeking and receiving the vac-
cination. These attitudes would include one’s perceived susceptibility to Q fever disease, per-
ceived severity of Q fever disease, perceived benefits of vaccination and perceived barriers to
vaccination [51]. A lack of perceived susceptibility and severity was evident among non-vacci-
nates in both cohorts, with the belief that they personally were not at risk of being severely
affected by Q fever the most influential reason for not seeking vaccination. This view may
reflect a lack of knowledge of the sources of infection and therefore the potential level of
Fig 3. Level of influence of sources of biosecurity information on veterinarians and veterinary nurses.
doi:10.1371/journal.pone.0146819.g003
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exposure for veterinary workers. For example, some workers may not be aware that companion
animals are a source of infection, believing that only livestock transmit the pathogen to
humans. This is likely in the nursing cohort at least, given that a quarter of veterinary nurses
surveyed identified that they did not know their potential risk of exposure to C. burnetii and
close to one fifth, the majority of whom were engaged in companion animal work, stated nil
exposure. Alternatively, those veterinary workers who might identify themselves as being at
high risk of acquiring Q fever may assume that they have already been exposed to C. burnetii
and are therefore immune and do not require vaccination.
Along with this lack of perceived vulnerability, perceived costs may be a key barrier to Q
fever vaccination [58]. These costs may include those of time and financial expense; as well as
difficulties involved in finding a Q fever vaccination provider as well as perceived and reported
adverse outcomes following vaccination. The results of this study indicate all of these factors
were somewhat influential barriers to vaccination for the participants of this study. These barri-
ers however, were equally influential for both veterinarians and veterinary nurses. An under-
standing of the reasons behind the gap in vaccination between these two cohorts can be gained
from the results of survey questions regarding reasons why participants sought vaccination.
The overwhelming majority of veterinarians in Australia received their Q fever vaccination
as a compulsory requirement of their university studies. This usually occurs during the early
years of veterinary or other animal science degrees, often with large numbers of students vacci-
nated on campus over a short time period or in organised vaccination clinics. Such vaccination
programs reduce the cost of vaccination, the difficulty sourcing a trained provider and the time
involved in being vaccinated. In addition, vaccination in this tertiary environment is driven by
recommendation from peers and health and safety protocols, along with a desire to avoid both
negative health and learning outcomes. Such adherence to subjective norms has been shown to
be an integral component of health models, such as the theory of planned behaviour [59].
In contrast, veterinary nursing in Australia is typically taught in the workplace with only
some nurses receiving supplementary or formal training via part time enrolment in technical
tertiary institutions. As such, outside of the controlled learning environment experienced by
veterinary students, veterinary nurses are typically not offered pre-arranged vaccination clinics
at a reduced cost, which are proven to maximise vaccine uptake [60]. Instead, they are often
required to seek out vaccination independently or rely on individual workplace vaccination
programs which may or may not be available in their workplace. In the former group, the barri-
ers to vaccination outlined above become much more influential, although there is anecdotal
evidence that an increasing number of veterinary clinics are now approaching Q fever vaccina-
tion as their responsibility.
The Australian national Q fever vaccination program is further evidence of the success of
vaccination en mass. The Australian government program funded the costs of screening and
vaccination of more than 50,000 abattoir workers, sheep shearers, farm workers and their fami-
lies. Workplace or community mass vaccination clinics were held, resulting in a program
uptake ranging from 60 to 100% in the initial phase [49]. Such results suggest vaccination clin-
ics targeting veterinary workers may help to improve vaccine uptake by veterinary nurses in
Australia and initial vaccine uptake by veterinary workers if the vaccine were introduced inter-
nationally. However, the logistics of such a task would not be straight forward, as most veteri-
nary clinics are small businesses as opposed to abattoirs and farming communities with a
substantially larger workforce. Cooperation from many veterinary hospitals within a region
would be required, highlighting the need for promotion and assistance from professional orga-
nisations, which in Australia could include the AVA or state veterinary registration boards.
This study also highlighted a potential issue surrounding lack of appropriate advice on Q
fever and vaccination from general medical practitioners in Australia. In some instances it is
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reported that Q fever vaccination of apparently at risk individuals was actively discouraged.
Further research is required to investigate the extent to which this is an issue among Australia’s
general practitioners, beyond those reported in this survey, the results of which may have
implications for vaccine introduction elsewhere.
Accessing the Australian veterinary workforce for the purpose of this study proved difficult
due to the absence of a governing central body through which the workforce could be con-
tacted. Despite state registration requirements for veterinarians, access via state veterinary
boards was limited as was contacting individuals via the AVA. Veterinary nurses were only
contactable by the Western Australia state veterinary board or the VNCA. It is expected that a
greater number of responses may be achieved for both cohorts with uniform access to individu-
als, rather than businesses, as demonstrated by the national AVA workforce survey of veteri-
narians distributed annually by all state boards to individuals for online completion. The AVA
workforce survey has achieved response rates varying from 15% to 29% of registered veterinari-
ans. In comparison, this survey received responses from 8.4% of veterinarians registered in
2014, however it is not directly comparable since not all registered veterinarians were contact-
able in the current study due to the inability to access them via state boards as was the case for
the AVA surveys. Other veterinary workforce studies in Australia have relied upon data collec-
tion from professional conferences; however these typically achieve smaller sample sizes and
greater selection bias among participants [39,61]. A novel approach to data collection was
required for this study to maximise the number of responses and reduce selection bias in order
to improve sample representativeness. Although this resulted in a non-uniform approach
across all states and the inability to accurately assess response rate, the numbers achieved were
remarkable.
The sample of veterinarians was considered representative of the workforce of veterinarians
in Australia as demonstrated by the fact that the number of veterinarian respondents by state
reflected similar proportions to the proportion of veterinarians registered in each state (S2
Table)[62]. In addition, the distribution of age and sex were comparable to those reported in
AVA national workforce surveys and Australian government statistics [47,62–64]. The propor-
tion engaged in each practice type was also similar to those reported in the AVA national work-
force surveys [62–64].
Currently there is little information available on the demographics of the Australian popula-
tion of veterinary nurses beyond Australian government employment statistics. These statistics
report 99% of Australian veterinary nurses are female which was reflected in the results of this
survey [48]. However, the veterinary nurse respondents in this study were older and more
highly educated than those reflected in government statistics and the states of Western Austra-
lia and New South Wales may be over-represented in this study while South Australia and
Queensland appear to be under-represented (S2 Table) [48]. Coverage bias associated with
web-based surveys is expected to be minimal due to the option of alternative methods for sur-
vey participation and the context of contact via the workplace and professional associations
[65].
The results of this study most likely indicate a ‘best-case’ scenario for this workforce for a
number of reasons. Firstly, a selection bias may have occurred towards participation from
those familiar with the subject and/or with a higher level of concern about Q fever [66]. Sec-
ondly, the veterinary nursing participants in this study had a higher level of formal qualifica-
tions than their profession as a whole. As a result, the knowledge and awareness of Q fever
could be expected to be lower in the greater population of veterinary workers, particularly
veterinary nurses. Additionally, self-reported levels of knowledge tend to be over-claimed
[67].
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Conclusion
Q fever vaccination uptake among veterinary nurses in Australia is well below uptake in veteri-
narians. The major barriers to vaccine uptake among the veterinary nurses participating in the
study included a lack of knowledge and awareness of Q fever disease and availability of vaccina-
tion. Additionally, most veterinary nurses were either not aware of their risk of Q fever or
reported nil perceived risk of exposure to C. burnetii. Veterinarians and clinic protocols were
reported as the main source of biosecurity information to veterinary nurses, however the low
levels of knowledge and uptake of the Q fever vaccine suggests that veterinarians and clinics
were not providing adequate WH&S information and training, in relation to Q fever, as is
required by Australian law. Other barriers to vaccination included financial expense, time, and
difficulty in finding a Q fever vaccine provider; these were influential on veterinarians also.
Veterinarians were mostly vaccinated in mass vaccination clinics during tertiary education,
reducing the impact of these barriers, and indicating the potential for workplace vaccination
clinics to improve the vaccination status of veterinary nurses. This study highlights the need
for additional studies to identify the drivers behind seeking and recommending vaccination so
that further recommendations on improving Q fever vaccine uptake by Australian veterinary
workers can be made. Evaluation of the knowledge and attitudes towards this vaccine among
the medical profession may also be warranted. Until then, some veterinary workers remain
unnecessarily at risk and unaware of the dangers posed to them by C. burnetii while veterinari-
ans and clinics may be failing to provide adequate duty of care.
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